Background Elevated proinflammatory cytokines are associated with greater COVID-19 severity.
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …

T cell immunity toward SARS-CoV-2 spike (S-), membrane (M-), and nucleocapsid (N-) proteins
may define COVID-19 severity. Therefore, we compare the SARS-CoV-2-reactive T cell …

The role of adaptive SARS-CoV-2 specific immunity in post-acute sequelae of COVID-19 (PASC)
is not well explored, although a growing population of convalescent COVID-19 patients …

SARS-CoV-2 variants of concern (VOCs) can trigger severe endemic waves and vaccine
breakthrough infections (VBI). We analyzed the cellular and humoral immune response in 8 …

Background. The ability of transplant (Tx) patients to generate a protective antiviral response
under immunosuppression is pivotal in COVID-19 infection. However, analysis of immunity …

Emerging variants of concern (VOC) raise obstacles in shaping vaccination strategies and
ending the pandemic. Vaccinated SARS-CoV-2 convalescence shapes the current immune …

Preventing the progression to acute respiratory distress syndrome (ARDS) in COVID-19 is
an unsolved challenge. The involvement of T cell immunity in this exacerbation remains …

The gut microbiota contributes to maintaining human health and regulating immune responses.
Severe COVID-19 illness is associated with a dysregulated pro-inflammatory immune …

Background The role of cellular immunity in pathogenesis of COVID-19 is unclear and
conflicting data points to insufficient or pathogenic immunity as drivers of COVID-19 progression. …

Identification of immunogenic targets of SARS-CoV-2 is crucial for monitoring of antiviral
immunity and vaccine design. Currently, mainly anti-spike (S)-protein adaptive immunity is …